Adaptive Biotechnologies Corp. (ADPT), a commercial stage biotechnology company, Monday reported that its fourth quarter revenue and full year revenue have increased by 51 percent and 55 percent respectively, compared to the same period last year.
ADPT shares were trading up 12.94 percent in the pre-market.
Quarterly revenue increased to around $72 million from $47.5 million and full year revenue grew to around $277 million from $179 million of last year.
The company plans to release its fourth quarter and full year results in February 2026.
In pre-market activity, ADPT shares were trading at $17.50, up 11.04% on Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 12, 2026 17:14 ET Major central bank action was the focus this week in economic news. The European Central Bank became the first major central bank to move in response to the rising inflationary pressures in the backdrop of the conflict in the Middle East. In North America, the U.S. inflation and trade data as well as Canada’s central bank decision gained attention. The Chinese trade data was the main news in Asia.